Article
IMMUNOGENETIC AND PHARMACOCHEMICAL CHARACTERIZATION OF THE ABO SYSTEM GLYCOPROTEIN PROPERTIES AS CRITERIA OF INDIVIDUAL SENSITIVITY TO ANTITUMOR AGENT BORTEZOMIB IN THE PLASMA CELL MYELOMA PATIENTS.
Problemy radiatsiinoi medytsyny ta radiobiolohii - 1 Dec 2019
Minchenko Zh M, Kustovska A D, Prymachenko S V, Dmytrenko O O, Liubarets T F, Shlyahtichenko T Yu, Balan V V, Bebeshko V G
Abstract excerpt
OBJECTIVE: Experimental study of the effect profile of bortezomib in the plasma cell myeloma (PCM) patients depend- ing on a specific phenotype carrier state and a pharmacochemical characteristics of ABO system glycoproteins. MATERIALS AND METHODS: The research was conducted on the 104 PCM patients, including the Chornobyl NPP acci- dent survivors (n = 49) and 65 study subjects in the comparison group....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.